Will Cannabis Genetics Be Restricted?

A redefinition of hemp under national law, set to take effect Nov. 12, signals the loss of Farm Bill safeguards for many hemp-derived THC items across the nation: low-dose beverages as well as THCA bud and delta-8 THC edibles, vapes and additional products sold at gas stations and https://nativesusa.com/ (https://nativesusa.com/) smoke shops.

But the hemp prohibition also generates a major complication for the legitimate cannabis industry. Seeds from cannabis varieties that generate flower with more than 0.3% THC are no longer legal to ship out of state.

Although seed purchases will likely continue in legal states, the changes threaten to close some seed banks and genetics businesses, observers note, while creating supply-chain issues for cannabis growers and retailers.

“If this language goes through, we will require pop-up stores to offer seeds in every state where it’s permitted,” Campanella said. “Which is why we’re also providing clones and tissue cultivation, because that’s not covered in the bill.”

When are cannabis seeds and clones prohibited to ship across state lines?

The new regulations categorize seeds depending on the THC capacity of the parent plant. Genetic material such as seeds and clones are rendered illegal if the final product crosses the threshold.

For the moment, seeds are currently shipping under the 2018 Farm Bill’s status quo. But the clock is ticking for businesses like Brothers Grimm and for cannabis cultivators who worry about supply chain interruptions if out-of-state access to genetics is banned.

Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics market, said Ryan Power, co-founder of Sebastopol, California-based breeder Atlas Seed.

Without government intervention in the form of an exception for seeds or an overall moratorium, many seed providers will just be shuttered by November, he added.

“We are operating legally now, but if that shifts, it will disrupt the legal licensed sector in each state,” said Power, whose clientele includes seed suppliers as well as licensed business cultivators.

“Customers are going to forfeit choice, and it will be a significant shutdown for most people.”

What are cannabis seed suppliers doing to remain legal after the government hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which strengthened cannabis supervision in that state while also restricting hemp-derived THC items to licensed cannabis retailers.

Formerly a seed bank, Silberhaze is now focused on the marketing, preservation and IP safeguarding of elite plant genetics.

That’s because seed companies hoping to stay compliant in this updated environment must have airtight documentation, he said.

“You have to demonstrate where this material comes from, so it’s extremely important to have records, even to the point where you have breeder names,” Silber said.

“Smaller businesses will have to work with better records and a better chain of custody,” he added. “We need that documentation ourselves, because we don’t want to be working with questionable sources.”

To prevent seizures and other legal consequences, seed entrepreneurs must “get their ducks in a row” before the updated regulations take place, Silber said.

“Review all your materials immediately, and classify what you can,” Silber said. “Take inventory, document your lineage, preserve breeder records, and arrange any cannabinoid or terpene data you currently have. If regulations change, you’ll be in a far better position to comprehend what may be affected and make informed decisions.”

Does government marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be required for businesses engaged in research.

But for the time being, seed houses can’t register with the DEA like state-licensed therapeutic cannabis operators can. Such a pathway is not available to seed suppliers, nurseries or genetics companies, said Jim Ickes, an attorney and partner with Frantz Ward’s cannabis law group in Cleveland.

“Genetics activity may be occurring inside broader state-licensed medical marijuana operations, as some states permit dispensaries or registered medical operators to sell seeds, clones or home-cultivation materials,” he said.

“But that is different from the DEA creating a freestanding seed supplier registration category.”

Some genetics companies are already changing operational practices to conform with the new law. According to Ickes, they must address questions including:

• Which of our lines produce plants over 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
• What does our catalog look like once we sort it against the viable-seed exclusion?

Ickes also recognizes confusion from clients who believed federal rescheduling of therapeutic marijuana would clarify their story with banking institutions. However, the recent regulatory wording has shifted those conversations past the basics of classification, he said.

“Financial institutions ask whether this specific revenue stream is lawful, whether it ties to state-licensed operations, or whether there’s interstate-commerce risk,” said Ickes.

“After November, a seed bank selling high-THC genetics can’t answer the initial question with the hemp definition. It has to refer to a lawful state cannabis pathway instead. Seed suppliers dealing in authentic industrial-hemp seed maintain the cleaner story.”

What’s the outlook of cannabis genetics?

Campanella is part of a emerging coalition of other breeders, farmers and researchers that’s arguing seeds are more appropriately defined as agricultural inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement work elsewhere.

“How do you control something based on what it could become one day?” said Campanella. “Our preference is to have that language removed, or get seeds regulated by the USDA as a hemp product.”

But in the meantime, Campanella is reorganizing Brothers Grimm to operate outside the scope of shifting federal oversight. The company plans to keep its Colorado seed operation while placing its Oklahoma tissue cultivation facility as a hedge against federal prohibition of cannabis seeds.

As she noted: “If things evolve in a way where we can’t focus on interstate shipping, we’ll have other resources to satisfy people’s needs without getting ourselves in trouble.”